| Suspended | Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive So HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer | Phase 1 | 2020-12-07 |
| Terminated | Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML o Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 / Phase 3 | 2018-12-27 |
| Active Not Recruiting | Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Hematologic Malignancy | Phase 1 | 2018-02-01 |
| Terminated | Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma Acute Myeloid Leukemia, Myelodysplastic Syndrome, Uveal Melanoma | Phase 1 / Phase 2 | 2017-04-14 |
| Terminated | Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child, Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | 2017-01-01 |
| Active Not Recruiting | Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant Leukemia, Myelodysplastic Syndromes, Lymphoma | Phase 1 | 2016-07-01 |
| Withdrawn | Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies Hematologic Malignancies | Phase 1 | 2016-07-01 |
| Withdrawn | Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT Leukemia, Myelodysplastic Syndromes, Lymphomas | Phase 1 | 2016-05-01 |
| Terminated | Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases Primary Immune Deficiency Disorders, Hemophagocytic Lymphohistiocytosis, Inherited Bone Marrow Failure Syndrome | Phase 1 | 2015-02-01 |
| Terminated | Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child, Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | 2014-04-01 |
| Active Not Recruiting | Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child, Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | 2014-04-01 |
| Completed | Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer Castrate Resistent Prostate Cancer | Phase 1 | 2013-04-01 |
| Active Not Recruiting | Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma | Phase 1 / Phase 2 | 2013-03-01 |
| Completed | MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer Castrate Resistant Prostate Cancer (CRPC) | Phase 1 | 2009-04-01 |
| No Longer Available | BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BP Hurler Syndrome, Inherited Metabolic Disorder, Lysosomal Storage Disorder | — | — |